SCHEMBL6086237

SCHEMBL6086237

CC(C)(C)C1=CCC(C)(C)c2cc(OCc3ccccc3)c(CCNc3ccc(C(=O)O)cc3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PTGER1 P34995 6/20 0.40
RXRA P19793 6/20 0.40
RXRB P28702 5/20 0.40
RXRG P48443 5/20 0.40
RARA P10276 1/20 0.38
RARB P10826 1/20 0.38
RARG P13631 1/20 0.38
MTNR1B P49286 1/20 0.38
PTGER4 P35408 1/20 0.37
PTGER3 P43115 1/20 0.37
PTGER2 P43116 1/20 0.37
CCNT1 O60563 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6086110 0.91 PPIA (0.41) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6086645 0.89 POLB (0.46) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6086318 0.87 POLB (0.44) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6086195 0.83 RXRA (0.38) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6086244 0.82 POLB (0.42) POLBMAPTTHRBPTGER1RXRA
SCHEMBL6086027 0.81 PPIA (0.43) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6085508 0.79 PPIA (0.41) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6086231 0.77 RXRA (0.46) POLBMAPTTHRBPTGER1RXRA
SCHEMBL6086081 0.76 PPIA (0.43) POLBMAPTTHRBMEN1KMT2A
SCHEMBL6089235 0.76 HNF4A (0.42) POLBMAPTTHRBRXRARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026487-B2 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity ALLERGAN, INC. (US) 2006-04-11 US disclosed
US-20040097733-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity BEARD RICHARD L (US) 2004-05-20 US disclosed
US-20030166932-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity ALLERGAN SALES, INC. 2003-09-04 US disclosed
US-6613917-B1 Retinoid agonist, antagonist or negative hormone-like biological activity ALLERGAN, INC. 2003-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166932-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity NR4A1, NR2E3, NR0B1 POLB 3117/4885MAPT 3421/4885THRB 22/4885
US-20040097733-A1 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity NR4A1, NR2E3, NR0B1 POLB 3117/4885MAPT 3421/4885THRB 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.